Adiponectin and barrett's esophagus

American Journal of Gastroenterology

Volumn 104, Issue 1, 2009, Pages 243-

  Fujita, Tetsuji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; CA 19-9 ANTIGEN; LEPTIN; PROTEIN BCL 2; PROTEIN KINASE B;

BARRETT ESOPHAGUS; CANCER RISK; CARCINOGENESIS; CHRONIC PANCREATITIS; COLORECTAL CARCINOMA; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME PHOSPHORYLATION; ESOPHAGEAL ADENOCARCINOMA; GASTROINTESTINAL CARCINOMA; HUMAN; LETTER; NONALCOHOLIC FATTY LIVER; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR GROWTH; BLOOD; GASTROINTESTINAL TUMOR; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPONECTIN; BARRETT ESOPHAGUS; GASTROINTESTINAL NEOPLASMS; HUMANS;

EID: 60749097824     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.29     Document Type: Letter

References (5)

1. Rubenstein JH, Dahlkemper A, Kao JY et al. A pilot study of the association of low plasma adiponectin and Barretfs esophagus. Am J Gastroenterol 2008;103:1358-64.
2. Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal disease. J Gastroenterol 2007;42:267-74.
3. Tilg H, Maschen AR. Role of adiponectin and PBET/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci 2008;114:275-88.
4. Ryan AM, Healy LA, Power DG et al. Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and proinflammatory state. Ann Surg 2008;247:909-15.
5. Kendall BJ, Macdonald GA, Hayward NK et al. Leptin and the risk of Barrett's esophagus. Gut 2008;57:448-54.